Fut2-null mice display an altered glycosylation profile and impaired BabA-mediated Helicobacter pylori adhesion to gastric mucosa.
Glycoconjugates expressed on gastric mucosa play a crucial role in host-pathogen interactions. The FUT2 enzyme catalyzes the addition of terminal alpha(1,2)fucose residues, producing the H type 1 structure expressed on the surface of epithelial cells and in mucosal secretions of secretor individuals. Inactivating mutations in the human FUT2 gene are associated with reduced susceptibility to Helicobacter pylori infection. H. pylori infects over half the world's population and causes diverse gastric lesions, from gastritis to gastric cancer. H. pylori adhesion constitutes a crucial step in the establishment of a successful infection. The BabA adhesin binds the Le(b) and H type 1 structures expressed on gastric mucins, while SabA binds to sialylated carbohydrates mediating the adherence to inflamed gastric mucosa. In this study, we have used an animal model of nonsecretors, Fut2-null mice, to characterize the glycosylation profile and evaluate the effect of the observed glycan expression modifications in the process of H. pylori adhesion. We have demonstrated expression of terminal difucosylated glycan structures in C57Bl/6 mice gastric mucosa and that Fut2-null mice showed marked alteration in gastric mucosa glycosylation, characterized by diminished expression of alpha(1,2)fucosylated structures as indicated by lectin and antibody staining and further confirmed by mass spectrometry analysis. This altered glycosylation profile was further confirmed by the absence of Fucalpha(1,2)-dependent binding of calicivirus virus-like particles. Finally, using a panel of H. pylori strains, with different adhesin expression profiles, we have demonstated an impairment of BabA-dependent adhesion of H. pylori to Fut2-null mice gastric mucosa, whereas SabA-mediated binding was not affected.
Magalhães
Ana
A
Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.
Gomes
Joana
J
Ismail
Mohd Nazri
MN
Haslam
Stuart M
SM
Mendes
Nuno
N
Osório
Hugo
H
David
Leonor
L
Le Pendu
Jacques
J
Haas
Rainer
R
Dell
Anne
A
Borén
Thomas
T
Reis
Celso A
CA
D018829:Adhesins, Bacterial / Q000378:metabolism / Q000502:physiology*; D000818:Animals; D001422:Bacterial Adhesion / Q000235:genetics; D002139:Caliciviridae / Q000378:metabolism; D050260:Carbohydrate Metabolism / Q000235:genetics; D002240:Carbohydrate Sequence; D005647:Fucosyltransferases / Q000235:genetics*; D005753:Gastric Mucosa / Q000737:chemistry / Q000378:metabolism* / Q000382:microbiology / Q000473:pathology; D054794:Glycomics; D006031:Glycosylation; D016481:Helicobacter Infections / Q000235:genetics / Q000473:pathology; D016480:Helicobacter pylori / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D011134:Polysaccharides / Q000032:analysis / Q000302:isolation & purification; D000097631:Galactoside 2-alpha-L-fucosyltransferase
D018829:Adhesins, Bacterial; D005647:Fucosyltransferases; D011134:Polysaccharides; D000097631:Galactoside 2-alpha-L-fucosyltransferase; C400429:BabA protein, Helicobacter pylori; C500808:SabA protein, Helicobacter pylori
J Biol Chem. 1983 Apr 25;258(8):4890-4
6833281
J Biol Chem. 1988 Apr 5;263(10):4576-85
3350806
Biochem J. 1997 Oct 1;327 ( Pt 1):105-15
9355741
Nat Rev Cancer. 2004 Jan;4(1):45-60
14681689
Science. 1998 Jan 16;279(5349):373-7
9430586
J Biol Chem. 2001 Jun 29;276(26):23748-56
11323419
Methods Enzymol. 2006;415:59-86
17116468
Gastroenterology. 2007 Aug;133(2):659-72
17681184
Cancer Res. 1986 Mar;46(3):1553-61
3510728
J Biol Chem. 1993 Oct 25;268(30):22782-7
7901202
J Biol Chem. 1984 Aug 25;259(16):10511-7
6469974
J Pathol. 2008 Jul;215(3):308-16
18498114
PLoS Pathog. 2006 Oct;2(10):e110
17121461
Glycobiology. 2005 Oct;15(10):1002-7
15958416
Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):2035-9
8383333
Glycobiology. 2009 Mar;19(3):309-20
19054801
Gastroenterology. 2002 Jun;122(7):1967-77
12055602
Annu Rev Pathol. 2006;1:63-96
18039108
J Biol Chem. 1997 Nov 21;272(47):29721-8
9368041
Lab Invest. 1985 Aug;53(2):219-27
2410664
Trends Microbiol. 1993 Oct;1(7):255-60
8162405
Cancer Res. 1986 Aug;46(8):3983-9
3524800
Science. 2004 Jul 23;305(5683):519-22
15273394
Nat Med. 2003 May;9(5):548-53
12692541
Mol Cell Biol. 2009 Jul;29(13):3770-82
19349303
J Biol Chem. 2003 Apr 18;278(16):14112-20
12562767
J Biol Chem. 1984 Apr 10;259(7):4681-5
6200484
Glycobiology. 2009 May;19(5):453-61
19150806
Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):971-7
11535550
J Clin Invest. 2008 Jun;118(6):2325-36
18483624
Anal Biochem. 1992 Nov 1;206(2):430-6
1280007
Glycobiology. 2009 Feb;19(2):182-91
18997175
Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1515-9
7878011
Glycobiology. 2007 Aug;17(8):17C-23C
17483136
J Biol Chem. 2008 Jun 20;283(25):17298-313
18411279
Clin Diagn Lab Immunol. 1997 Sep;4(5):540-4
9302202
J Biol Chem. 1983 Oct 10;258(19):11793-7
6194156
J Biol Chem. 1995 Oct 20;270(42):25047-56
7559635
Glycobiology. 2009 Apr;19(4):399-407
19106234
Glycoconj J. 2009 Dec;26(9):1125-34
19326211
J Biol Chem. 1987 Feb 5;262(4):1596-601
3805045
J Biol Chem. 1998 May 8;273(19):11533-43
9565568
Mol Cell Biol. 2001 Dec;21(24):8336-45
11713270
Rev Fr Transfus Immunohematol. 1987 Dec;30(5):681-4
2455325
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12778-83
10535999
Glycoconj J. 2009 Jul;26(5):511-23
19089612
Cancer Res. 1988 Oct 1;48(19):5422-6
3166398
J Biol Chem. 1991 Jan 5;266(1):83-8
1985926
Vox Sang. 1992;62(3):180-9
1609521
Glycobiology. 1993 Apr;3(2):97-130
8490246
PLoS Pathog. 2008 Jan;4(1):e2
18179282
Science. 1993 Dec 17;262(5141):1892-5
8018146
J Pathol. 2006 May;209(1):88-94
16456898
J Med Microbiol. 2001 Apr;50(4):320-329
11289517
Science. 2002 Jul 26;297(5581):573-8
12142529
J Biol Chem. 1996 Apr 5;271(14):8250-9
8626519